Company Deep Dive
Business segments breakdown, earnings transcript analysis, management credibility scoring, competitive landscape, and scenario modelling.
VTR.MX
BUYVentas, Inc. · Real Estate · United States · $41.8B · Avg Vol: $72K/d
COMPANY DESCRIPTION
Ventas, Inc. is a leading S&P 500 real estate investment trust enabling exceptional environments that benefit a large and growing aging population. With approximately 1,400 properties in North America and the United Kingdom, Ventas occupies an essential role in the longevity economy.
FINANCIAL SUMMARY (USD)
| Year | 2022 | 2023 | 2024 | 2025 | CAGR | TTM | 2026E | 2027E | Fwd CAGR |
|---|---|---|---|---|---|---|---|---|---|
| Revenue | 4.1B | 4.5B | 4.9B | 5.8B | 12.2% | 6.1B | 6.9B | 7.7B | 14.6% |
| EPS | -0.12 | -0.10 | 0.20 | 0.55 | 175.0% | 0.55 | — | — | — |
| Shares | 399.7M | 402.1M | 437.1M | 474.9M | +18.8% | 486.2M | — | — | — |
| Debt | 12.5B | 13.7B | 13.7B | 13.2B | 1.9% | 12.7B | — | — | — |
| Equity | 10.2B | 9.5B | 10.8B | 12.5B | 7.3% | — | — | — | — |
| Op CF | 1.1B | 1.1B | 1.3B | 1.6B | 13.7% | 1.7B | — | — | — |
| Inv CF | -859.2M | -184.7M | -2.4B | -2.7B | — | — | — | — | — |
| Fin CF | -283.9M | -543.7M | 1.4B | 873.8M | — | — | — | — | — |
SCORE BREAKDOWN
FUNDAMENTALS
SECTOR PEERS
Closest peers in Real Estate, ranked by industry match, size, and score similarity. Cross-listings of VTR.MX are excluded.
| Ticker | Company | Mkt Cap | StockRank | Signal |
|---|---|---|---|---|
| VTR.MX | Ventas, Inc.(you) | $41.8B | 66 | BUY |
| DOC | Healthpeak Properties, Inc. | $14.9B | 73 | BUY |
| OHI | Omega Healthcare Investors, Inc. | $15.0B | 81 | STRONG BUY |
| AHR | American Healthcare REIT, Inc. | $10.5B | 51 | HOLD |
| SBRA | Sabra Health Care REIT, Inc. | $4.9B | 66 | BUY |
| WELL | Welltower Inc. | $160.5B | 49 | HOLD |
| CTRE | CareTrust REIT, Inc. | $9.6B | 83 | STRONG BUY |
| HR | Healthcare Realty Trust Incorporated | $7.2B | 51 | HOLD |
| MPT | Medical Properties Trust, Inc. | $2.7B | 74 | BUY |
| NHI | National Health Investors, Inc. | $3.8B | 48 | HOLD |
Peer medians: ROE 5.8% · P/E 26.6x · Gross margin 67.5%